UNSPSC 51144115: Dextroamphetamine

This classification denotes a cns stimulant with the molecular formula C9H13N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TZ47U051FI, chemically known as phenethylamine, alpha-methyl-, d- but more generally known as dexamfetamine, which bears US NIH Compound Identifier 5826. European Medicines Agency schedules Dexamfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07019MIG. The term DEXAMFETAMINE is an International Non-Proprietary Name.

UNSPSC 51144115 Dextroamphetamine is a Commodity code that does not align with the recent state and local procurement activity posted under it. The most recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, neither of which falls within the scope of dextroamphetamine procurement. The mismatch between the code's nominal scope and actual current buying activity suggests either a data-tagging error or that the code sees minimal relevant procurement use in the state and local market right now.

The single recent opportunity on record shows Seminole County seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. Vendors must include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify requirements. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period. Without additional opportunities in the recent-opportunities block that actually match dextroamphetamine procurement, the code does not present a clear market signal for business development pursuit at this time.